Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,265.00 ILa | -2.83% |
|
-8.99% | -8.18% |
| 06-18 | FDA Seeks Updated Labeling for Testosterone Therapies | MT |
| 06-18 | Teva Submits New Drug Application for Ecopipam to Treat Pediatric Tourette Syndrome | MT |
| Market Cap | 36.66B 0 31.94B 29.44B 27.69B 51.81B 3,455B 52.17B 350B 136B 1,703B 138B 135B 5,901B | P/E 2026 * |
31.6x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 47.69B 0 41.55B 38.3B 36.03B 67.4B 4,494B 67.87B 456B 177B 2,215B 179B 175B 7,677B | EV / Sales 2026 * |
2.86x | EV / Sales 2027 * | 2.59x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | -2.83% | ||
| 1 week | -8.99% | ||
| Current month | -5.84% | ||
| 1 month | -7.99% | ||
| 3 months | -0.11% | ||
| 6 months | -4.14% | ||
| Current year | -8.18% |
| 1 week | 9,250 |  | 10,230 |
| 1 month | 9,250 | | 10,240 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 2,695 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 21,770 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 2022-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 2019-12-21 |
Matthew Shields
COO | Chief Operating Officer | 52 | 2024-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 2008-12-31 |
Sol Barer
CHM | Chairman | 78 | 2017-02-05 |
Rosemary Crane
BRD | Director/Board Member | 65 | 2015-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | -8.99% | - | - | 37.91B | |
| -1.21% | -5.37% | +39.94% | +145.38% | 992B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 564B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 391B | |
| -1.18% | +0.25% | +25.86% | +16.53% | 330B | |
| -2.36% | -3.12% | +24.71% | +11.59% | 280B | |
| -2.45% | -2.88% | +24.29% | +30.06% | 279B | |
| -1.91% | -0.87% | -41.95% | -49.25% | 196B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 184B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 156B | |
| Average | -1.91% | -1.98% | +19.14% | +39.27% | 374.58B | |
| Weighted average by Cap. | -1.78% | -2.88% | +28.03% | +63.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.65B 0 14.51B 13.37B 12.58B 23.53B 1,569B 23.7B 159B 61.79B 773B 62.49B 61.15B 2,680B | 17.26B 0 15.04B 13.86B 13.04B 24.39B 1,627B 24.57B 165B 64.05B 802B 64.79B 63.4B 2,779B |
| Net income | 1.74B 0 1.51B 1.39B 1.31B 2.45B 164B 2.47B 16.6B 6.45B 80.66B 6.52B 6.38B 280B | 2.72B 0 2.37B 2.18B 2.05B 3.84B 256B 3.87B 25.99B 10.09B 126B 10.21B 9.99B 438B |
| Net Debt | 11.03B 0 9.61B 8.86B 8.33B 15.59B 1,040B 15.7B 105B 40.94B 512B 41.41B 40.52B 1,776B | 8.01B 0 6.98B 6.44B 6.05B 11.32B 755B 11.4B 76.57B 29.74B 372B 30.08B 29.43B 1,290B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 9,265.00 ILa | -2.83% | 1,141,221 |
| 26-06-17 | 9,535.00 ILa | -1.69% | 810,016 |
| 26-06-16 | 9,699.00 ILa | -2.52% | 904,000 |
| 26-06-15 | 9,950.00 ILa | -2.16% | 795,091 |
| 26-06-12 | 10,170.00 ILa | -0.10% | 281,971 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
